Projects funded by the NCN
Pharmacogenetics of thiopurine drugs in patients with inflammatory bowel disease - application of the newest methods of DNA sequencing for the deepened analysis of the genetic factors involved in the response to treatment.
2016/23/D/NZ2/01620
Keywords:
thiopurine drugs pharmacogenetics inflammatory bowel diseases next generation sequencing
Descriptors:
- NZ2_2: Genomics, transcriptomics, epigenomics
- NZ2_1: Molecular genetics
Panel:
NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Host institution :
Instytut Genetyki Człowieka Polskiej Akademii Nauk
woj. wielkopolskie
Principal investigator (from the host institution):
dr Marzena Skrzypczak-Zielińska
Number of co-investigators in the project: 8
Call: SONATA 12 - announced on 2016-09-15
Amount awarded: 902 196 PLN
Project start date (Y-m-d): 2017-08-30
Project end date (Y-m-d): 2022-08-29
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.